companydata.dkcompanydata.dk

ASTION PHARMA A/S: Financial statements 2016

CVR: 34224781

Source: annual report 2016, Danish Business Authority

01/01/2016 – 31/12/2016

ASTION PHARMA A/S (CVR 34224781) has filed annual accounts for 2016. In 2016, the company reported a gross profit of DKK -187,484 and a net result of DKK 116,538 compared with DKK -5,768,474 the year before. Equity in the 2016 report amounted to DKK 15,667,771. The solvency ratio was 92.9%.

Gross Profit
DKK -187,484
Profit/Loss
DKK 116,538
Equity
DKK 15,667,771
Total Assets
DKK 16,856,337
Employees
0

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2016--187 t.117 t.15.7 mio.0
2015--783 t.-5.8 mio.15.6 mio.-
2014--1.2 mio.-3.4 mio.21.3 mio.-
2013--804 t.-1.5 mio.24.8 mio.-
2012--1.1 mio.-1.9 mio.26.3 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like ASTION PHARMA A/S

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2016

ASTION PHARMA A/S: The 2015 annual report is outJun 1, 2016

ASTION PHARMA A/S has published its annual report for 2015. Gross profit came to DKK -783,072, and the net result was DKK -5,768,474.

About ASTION PHARMA A/S

ASTION PHARMA A/S is a Danish company of the type Aktieselskab based in Vissenbjerg, founded in 2012. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named AP NEWCO A/S. The management consists of Torben Rønje. The board consists of Ib Henrik Rønje (chair), Henrik Grønfeldt-Sørensen and Torben Rønje. The company is owned by KAPITALFORMIDLINGS INSTITUTTET A/S. The company has 0 employees (2017). In 2025, the company reported a gross profit of DKK -18,071 and a net result of DKK -164,736 compared with DKK -246,248 the year before. Equity in the 2025 report amounted to DKK -5,950,429.

Source: annual report 2025, Danish Business Authority